Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Actarit

Actarit

pharmaceutical raw materials
Actarit structure

Actarit 

structure
  • CAS No:

    18699-02-0

  • Formula:

    C10H11NO3

  • Chemical Name:

    Actarit

  • Synonyms:

    Benzeneacetic acid,4-(acetylamino)-;Acetic acid,(p-acetamidophenyl)-;4-(Acetylamino)benzeneacetic acid;4-(N-Acetylamino)phenylacetic acid;p-Acetamidophenylacetic acid;MS 932;4-(Acetylamino)phenylacetic acid;Actarit;(4-Acetamidophenyl)acetic acid;NSC 170317;2-(4-Acetamidophenyl)acetic acid

  • Categories:

    Biochemical Engineering  >  Biological Response Modifiers

Description

Crystalline SolidActarit is an orally administered disease-modifying antirheumatic drug launched in Japan. Although its structure resembles that of non-steroidal anti-inflammatory drugs, it has no effect on experimental acute inflammation and has no analgesic or antipyretic effects. Its preventative and therapeutic effects on adjuvant arthritis are mediated via modulation of production and serum level of interleukin-2 which enhances production of suppressor T-cells to the immune system, th


Actarit is an anilide and a member of acetamides.

Actarit Basic Attributes

193.2

193.20

242-511-3

HW5B6351RZ

170317

DTXSID0020020

29163990

Characteristics

66.4

0.8

1.288±0.06 g/cm3(Predicted)

173 °C

449.1±28.0 °C(Predicted)

225.4±24.0 °C

1.605

>29 [ug/mL]

-20°C

LD50 in male, female mice, male, female rats (mg/kg): 1.06, 1.30, 1.95, 2.03 i.p.; 5.68, 5.48, 5.48, 6.12 s.c.; 15.3, 14.7, 14.8, 15.4 orally (Toshida)

Safety Information

II

8

2987

R34:Causes burns.

24/25

CY1542000

C

Drug Information

Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)

4-(acetylamino)benzeneacetic acid

Actarit Use and Manufacturing

Methods of Manufacturing

p-Aminophenylacetic acid (1.02 mmol) (manufactured by Wako Pure Chemical Industries) was dissolved indichloromethane-methanol-water (1:3:1, 50 ml), and acetic anhydride (2.12 mmol) was added thereto under ice-cooling, followed by stirring overnight while gradually returning to room temperature. The solvent was evaporated under reducedpressure to give the titled compound (196.4 mg, yield 99percent). The structure was identified by 1H-NMR1H-NMR (500 MHz, CD3OD) d (ppm) = 2.11 (3H, s, Ac), 3.55 (2H, s, Ph-CH2-), 7.21-7.49 (4H, m, Aromatic H)To a stirred solution of 2-(4-aminophenyl) acetic acid (2.0 g, 13.23 mmol) and TEA (3.66 mL, 26.5 mmol) in DCM (20 mL) at RT was added acetic anhydride (1.25 1 mL, 13.23 mmol) drop wise and the reaction mixture was stirred for 16 hours at RT. The reaction mixture was acidified, diluted with DCM (30 mL) and the organic layer was washed with water (10 mL) and brine (10 mL), dried over sodium sulphate, concentrated to obtain the title compound(1.2 g, 46 percent).To a stirred solution of 4-aminophenylacetic acid (31.5 g, 0.209 mol) in acetonitrile (550 ml) was added acetic anhydride (57 ml), sodium carbonate (66.5 g, 0.627 mol) and water (55 ml). The reaction was allowed to stir at room temperature for 3 hours. Reaction mixture was then poured onto a solution of conc. HCI (130 ml) and water (1200 ml). Reaction mixture was then extracted with EtOAc (2 x 750 ml). Combined organic layers were dried over MgSO4, filtered and evaporated under reduced pressure to reveal a tan solid. Purification by column chromatography [Si02 : 100percent DCM to 10percent MeOH/DCM] afforded a light tan solid (16. 5g, 41 percent).According to a reported procedure [49], 4-aminophenylaceticacid (4, 2.0 g) was added to acetic acid (20 mL) under microwave irradiation (150 °C) for 1 h. Thereaction mixture was poured into ethyl acetate then washed with water and then allowed to dry toyield the compound 8 (Scheme 9; 2.252 g; 100percent) as a white-grey solid. m.p. 166–168 °C [57]. 1H-NMR(300 MHz, DMSO-d6): δ = 9.92 (s, 1H), 7.51 (d, 3J = 8.6 Hz, 2H), 7.16 (d, 3J = 8.6 Hz, 2H), 3.49 (s, 1H), 2.03 (s, 3H). 13C-NMR (75 MHz, DMSO-d6): δ = 172.79 (Cq), 172.02 (Cq), 168.13 (Cq), 137.83 (Cq), 129.52(CH), 118.87 (CH), 40.11 (CH2), 23.87 (CH3). IR: 3348 (w), 1709 (s), 1638 (m), 1601 (s), 1542 (s), 1538 (s), 1221 (m), 1195 (m), 968 (w), 806 (w), 723 (w). 1H-NMR (400 MHz, CD3OD): δ 7.48 (d, J = 8.8 Hz, 2H), 7.21 (d, J = 8.8 Hz, 2H), 3.55 (s, 2H), 2.10 (s, 3H); HRMS (FAB+): [M + H]+ calcd. for C10H12O3N, 194.0817; found, 194.0770.mixing p-aminophenylacetic acid, N, N-dimethylacetamide and ammonium chloride, heating to 168 ° C, refluxing for 2 h, and then cooling to room temperature, Add ice water to 4 , insulation crystallization 50min, filtration, washing with ice water filter cake, adjust the temperature to 65 , vacuum drying 4.5h to be acetamidophenylacetic acid, of which p-aminophenylacetic acid, N, N-bis The weight ratio (g / ml) ratio of methylacetamide is 3:15, the weight ratio of p-aminophenylacetic acid and ammonium chloride is 3: 1.5, and the weight ratio of p-aminophenylacetic acid to ice water during crystallization is For 3: 8.

Uses

Chronic rheumatoid arthritis

Computed Properties

Molecular Weight:193.20
XLogP3:0.8
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:193.07389321
Monoisotopic Mass:193.07389321
Topological Polar Surface Area:66.4
Heavy Atom Count:14
Complexity:219
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

It may be related to the inhibition of the production of IL-1β, IL-6, TNF-α and MMP-1 in the synovial cells of the patient's joint cavity. It has a control effect on the development of arthritis lesions in rheumatoid arthritis-related model animals and improves the condition of rheumatoid arthritis patients, but has no analgesic and anti-inflammatory effects.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Suzhong Pharmaceutical Group Co., Ltd.

    China China
    Active
  • Hefei Pingguang Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Actarit

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.